Annual Shareholders Equity
$33.57 M
+$44.21 M+415.50%
December 31, 2023
Summary
- As of February 8, 2025, PLX annual stockholders equity is $33.57 million, with the most recent change of +$44.21 million (+415.50%) on December 31, 2023.
- During the last 3 years, PLX annual shareholders equity has risen by +$60.61 million (+224.16%).
- PLX annual shareholders equity is now -47.29% below its all-time high of $63.69 million, reached on December 31, 2007.
Performance
PLX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$32.44 M
+$3.86 M+13.49%
September 30, 2024
Summary
- As of February 8, 2025, PLX quarterly stockholders equity is $32.44 million, with the most recent change of +$3.86 million (+13.49%) on September 30, 2024.
- Over the past year, PLX quarterly shareholders equity has dropped by -$5.81 million (-15.19%).
- PLX quarterly shareholders equity is now -49.07% below its all-time high of $63.69 million, reached on December 31, 2007.
Performance
PLX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PLX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +415.5% | -15.2% |
| 3 y3 years | +224.2% | -15.2% |
| 5 y5 years | +163.5% | -15.2% |
PLX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +415.5% | -16.8% | +381.7% |
| 5 y | 5-year | at high | +147.7% | -16.8% | +146.1% |
| alltime | all time | -47.3% | +147.7% | -49.1% | +145.8% |
Protalix BioTherapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $32.44 M(+13.5%) |
| Jun 2024 | - | $28.58 M(-4.0%) |
| Mar 2024 | - | $29.79 M(-11.3%) |
| Dec 2023 | $33.57 M(-415.5%) | $33.57 M(-12.2%) |
| Sep 2023 | - | $38.25 M(-1.9%) |
| Jun 2023 | - | $39.00 M(+3769.1%) |
| Mar 2023 | - | $1.01 M(-109.5%) |
| Dec 2022 | -$10.64 M(+76.3%) | -$10.64 M(-7.6%) |
| Sep 2022 | - | -$11.51 M(+16.4%) |
| Jun 2022 | - | -$9.89 M(+32.1%) |
| Mar 2022 | - | -$7.49 M(+24.0%) |
| Dec 2021 | -$6.04 M(-77.7%) | -$6.04 M(-2933.8%) |
| Sep 2021 | - | $213.00 K(-94.5%) |
| Jun 2021 | - | $3.84 M(-73.5%) |
| Mar 2021 | - | $14.50 M(-153.6%) |
| Dec 2020 | -$27.04 M(-61.6%) | -$27.04 M(-18.8%) |
| Sep 2020 | - | -$33.31 M(-4.2%) |
| Jun 2020 | - | -$34.76 M(+12.6%) |
| Mar 2020 | - | -$30.88 M(-56.1%) |
| Dec 2019 | -$70.32 M(+33.0%) | -$70.32 M(-0.7%) |
| Sep 2019 | - | -$70.85 M(+5.0%) |
| Jun 2019 | - | -$67.48 M(+12.7%) |
| Mar 2019 | - | -$59.85 M(+13.2%) |
| Dec 2018 | -$52.88 M(+79.5%) | -$52.88 M(-18.6%) |
| Sep 2018 | - | -$64.99 M(+31.1%) |
| Jun 2018 | - | -$49.57 M(+25.7%) |
| Mar 2018 | - | -$39.44 M(+33.9%) |
| Dec 2017 | -$29.46 M(+195.8%) | -$29.46 M(+13.0%) |
| Sep 2017 | - | -$26.07 M(+26.1%) |
| Jun 2017 | - | -$20.67 M(-69.8%) |
| Mar 2017 | - | -$68.47 M(+587.7%) |
| Dec 2016 | -$9.96 M(-191.6%) | -$9.96 M(-34.1%) |
| Sep 2016 | - | -$15.10 M(+89.4%) |
| Jun 2016 | - | -$7.98 M(-401.0%) |
| Mar 2016 | - | $2.65 M(-75.6%) |
| Dec 2015 | $10.87 M(-119.6%) | $10.87 M(-115.9%) |
| Sep 2015 | - | -$68.51 M(+5.2%) |
| Jun 2015 | - | -$65.14 M(+6.5%) |
| Mar 2015 | - | -$61.15 M(+10.0%) |
| Dec 2014 | -$55.60 M(+106.3%) | -$55.60 M(+16.6%) |
| Sep 2014 | - | -$47.69 M(+19.9%) |
| Jun 2014 | - | -$39.79 M(+18.5%) |
| Mar 2014 | - | -$33.58 M(+24.6%) |
| Dec 2013 | -$26.95 M(+702.7%) | -$26.95 M(+61.3%) |
| Sep 2013 | - | -$16.71 M(+39.4%) |
| Jun 2013 | - | -$11.99 M(+90.8%) |
| Mar 2013 | - | -$6.28 M(+87.2%) |
| Dec 2012 | -$3.36 M(-87.1%) | -$3.36 M(-170.3%) |
| Sep 2012 | - | $4.77 M(-39.3%) |
| Jun 2012 | - | $7.86 M(-221.8%) |
| Mar 2012 | - | -$6.46 M(-75.2%) |
| Dec 2011 | -$26.08 M | -$26.08 M(+50.3%) |
| Sep 2011 | - | -$17.35 M(+99.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2011 | - | -$8.70 M(-285.0%) |
| Mar 2011 | - | $4.71 M(-141.6%) |
| Dec 2010 | -$11.32 M(-171.3%) | -$11.32 M(+219.8%) |
| Sep 2010 | - | -$3.54 M(+127.9%) |
| Jun 2010 | - | -$1.55 M(-118.9%) |
| Mar 2010 | - | $8.21 M(-48.3%) |
| Dec 2009 | $15.88 M(-64.2%) | $15.88 M(-47.2%) |
| Sep 2009 | - | $30.08 M(-13.9%) |
| Jun 2009 | - | $34.91 M(-11.9%) |
| Mar 2009 | - | $39.63 M(-10.6%) |
| Dec 2008 | $44.35 M(-30.4%) | $44.35 M(-12.2%) |
| Sep 2008 | - | $50.49 M(-10.6%) |
| Jun 2008 | - | $56.51 M(-7.0%) |
| Mar 2008 | - | $60.75 M(-4.6%) |
| Dec 2007 | $63.69 M(+162.3%) | $63.69 M(+183.4%) |
| Sep 2007 | - | $22.47 M(-10.5%) |
| Jun 2007 | - | $25.10 M(-9.1%) |
| Mar 2007 | - | $27.62 M(+13.7%) |
| Dec 2006 | $24.28 M(+298.4%) | $24.28 M(+2842.1%) |
| Sep 2006 | - | $825.40 K(-11.4%) |
| Jun 2006 | - | $932.10 K(+3.2%) |
| Mar 2006 | - | $903.20 K(-85.2%) |
| Dec 2005 | $6.09 M(+1131.3%) | $6.09 M(+1284.3%) |
| Sep 2005 | - | $440.30 K(-6.8%) |
| Jun 2005 | - | $472.20 K(-2.6%) |
| Mar 2005 | - | $485.00 K(-2.0%) |
| Dec 2004 | $495.00 K(-24.5%) | $495.00 K(-6.1%) |
| Sep 2004 | - | $526.90 K(-7.6%) |
| Jun 2004 | - | $570.20 K(-9.3%) |
| Mar 2004 | - | $628.70 K(-4.1%) |
| Dec 2003 | $655.40 K(-17.7%) | $655.40 K(-6.6%) |
| Sep 2003 | - | $701.60 K(-4.4%) |
| Jun 2003 | - | $733.90 K(-3.9%) |
| Mar 2003 | - | $763.70 K(-4.1%) |
| Dec 2002 | $796.10 K(-15.8%) | $796.10 K(-5.9%) |
| Sep 2002 | - | $845.80 K(-3.7%) |
| Jun 2002 | - | $878.00 K(-3.5%) |
| Mar 2002 | - | $910.20 K(-3.8%) |
| Dec 2001 | $945.90 K(-29.6%) | $945.90 K(-5.6%) |
| Sep 2001 | - | $1.00 M(-4.6%) |
| Jun 2001 | - | $1.05 M(-10.4%) |
| Mar 2001 | - | $1.17 M(-12.8%) |
| Dec 2000 | $1.34 M(-15.4%) | $1.34 M(-11.4%) |
| Sep 2000 | - | $1.52 M(+0.8%) |
| Jun 2000 | - | $1.50 M(-2.8%) |
| Mar 2000 | - | $1.55 M(-2.6%) |
| Dec 1999 | $1.59 M(-52.6%) | $1.59 M(-30.6%) |
| Sep 1999 | - | $2.29 M(-14.0%) |
| Jun 1999 | - | $2.66 M(-12.0%) |
| Mar 1999 | - | $3.03 M |
| Dec 1998 | $3.35 M(>+9900.0%) | - |
| Dec 1997 | $0.00(0.0%) | - |
| Dec 1996 | $0.00 | - |
FAQ
- What is Protalix BioTherapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics annual shareholders equity year-on-year change?
- What is Protalix BioTherapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics quarterly shareholders equity year-on-year change?
What is Protalix BioTherapeutics annual stockholders equity?
The current annual shareholders equity of PLX is $33.57 M
What is the all time high annual shareholders equity for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high annual stockholders equity is $63.69 M
What is Protalix BioTherapeutics annual shareholders equity year-on-year change?
Over the past year, PLX annual stockholders equity has changed by +$44.21 M (+415.50%)
What is Protalix BioTherapeutics quarterly stockholders equity?
The current quarterly shareholders equity of PLX is $32.44 M
What is the all time high quarterly shareholders equity for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high quarterly stockholders equity is $63.69 M
What is Protalix BioTherapeutics quarterly shareholders equity year-on-year change?
Over the past year, PLX quarterly stockholders equity has changed by -$5.81 M (-15.19%)